NYSE:ORCL

Oracle (ORCL)

146.99
+5.14 (3.62%)
as of Aug 4, 2026, 6:11:38 pm Market Open.
302 watching
0
Investor Insights
star iconAug 3, 2026, 12:00 am

This summary was created by AI, based on 46 opinions in the last 12 months.

Oracle Corporation is currently experiencing a tumultuous period marked by significant volatility and market skepticism towards its heavy investments in AI and data centers. Although the company recently reported better-than-expected earnings, concerns about its rising debt levels and cash flow issues continue to loom over investor sentiment. Many analysts see potential in Oracle's long-term earnings growth, particularly through its AI initiatives, projecting substantial EPS increases by 2030. However, a strong reliance on AI and concerns about competition, particularly from better-capitalized peers, has led to caution among experts, with a significant number recommending to hold or wait before making further investments. Despite some optimistic projections, the overall view remains cautious, with calls for prudent positioning amidst ongoing uncertainties in the tech sector.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Overvalued
review icon
Similar
Microsoft, MSFT
BUY

Is in the sweet spot, AI, and giving excellent results. Momentum is there. All systems go. The only negative is its valuation, but its momentum trumps that.

BUY

Is seeing billions in orders to build data centres. It popped 4% today, up over 31% this year.

WEAK BUY

Hasn't had a chance to look closely at yesterday's earnings. Stock's at a 52-week, if not all-time, high today. Looks interesting, given the cloud space it's in. Not expensive at 2x PEG, with forward PE of 29-30x. Earnings growth rate ~16%.

Technically, meets his criteria. 200-day MA is trending higher, and price is above that. High beta, volatile.

BUY

They report Wednesday. The stock plunged after their last report, but has surprisingly bounced back. He expect good revenue growth this growth, driven by data centres.

BUY ON WEAKNESS

Has been beaten down along with anything related to data centres, but was up 3.27% today. Its multiple has compressed so much that the stock is now cheap.

HOLD

Selling off with general selloff in tech. Great CEO.

BUY

Oracle was a little late pivoting from hardware to software, but have very deep pockets so they now own #4 in cloud. He targets $207.

BUY

It reports Monday. A good software company that's become a great data centre company. But AI stocks have not traded the same since DeepSeek  late January. That said, he expects Oracle to say good things.

WAIT

They had a giant move after delivering great news, but now we're waiting for more great news. So, you have to wait till March 11 for their next report.

HOLD

Taken to the woodshed this week, mainly due to Trump and Stargate last week. He's been buying this week. No one's brought their price targets down. Monday may have been difficult, but it's a great opportunity to put some cash to work.

Pivoted nicely the way MSFT and IBM did years ago. Fourth main player in the cloud, which gives them recurring revenue. Best at cross-selling.

(Analysts’ price target is $207.00)
COMMENT

Trades at 26x PE and its last quarter was merely okay. He screwed up when he sold it and shares moved up after. He can't comment on this.

TOP PICK

He targets $207.35. Operates three segments, including cloud. A great turnaround story to get into the cloud, now #4. They reported Nov. 5 and missed top and bottom lines. Shares traded off, but others snapped up those shares. They recently did a big partnership with Meta. The forward PE is an attractive 31x. Has 15% upside.

(Analysts’ price target is $197.84)
DON'T BUY

It missed its last quarter and stocks that missed are being punished now and in the future until we hear better economic news. This will head further down.

BUY

They report Monday. They build in-demand data centres, so he expects incredible strength in their report.

WEAK BUY
ORCL vs. DELL

He owns both.

Took a bit of profit on DELL. Still holds about a 3-3.5% position in ORCL. If he had to choose, he'd say ORCL (at $189 now), for which his 12-month price target is $207.50.

Showing 46 to 60 of 378 entries